During the past decade, Johns Hopkins Burn Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Johns Hopkins Burn Center" #1 sponsor was "Johns Hopkins University" with 2 trials, followed by "MediWound Ltd" with 1 trials sponsored, "Mylan Inc." with 1 trials sponsored, "Noveome Biotherapeutics, formerly Stemnion" with 1 trials sponsored and "PolyNovo Biomaterials Pty Ltd." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Johns Hopkins Burn Center" #1 collaborator was "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator, "Congressionally Directed Medical Research Programs" with 1 trials as a collaborator, "Mylan Bertek Pharmaceuticals" with 1 trials as a collaborator, "U.S. Department of Education" with 1 trials as a collaborator and "United States Department of Defense" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Johns Hopkins Burn Center" are "Burns" (3 trials), "Acute Pain" (1 trials), "Mood Disorders" (1 trials), "Posttraumatic Stress Disorder" (1 trials) and "Sleep Disorders" (1 trials). Many other conditions were trialed in "Johns Hopkins Burn Center" in a lesser frequency.

Most popular intervention types in "Johns Hopkins Burn Center" are "Drug" (3 trials), "Behavioral" (1 trials), "Biological" (1 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cognitive Behavioral Therapy" (1 trials), "Fentanyl" (1 trials), "NexoBrid" (1 trials), "NovoSorb BTM" (1 trials) and "ST266" (1 trials). Other intervention names were less common.

The vast majority of trials in "Johns Hopkins Burn Center" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Johns Hopkins Burn Center". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Johns Hopkins Burn Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Johns Hopkins Burn Center, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".